Evidence map›Paper›PMID 32490199›Full record

ArticleScience advances2020

Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal.

Elana Ben-Akiva, Randall A Meyer, Hongzhe Yu, Jonathan T Smith, Drew M Pardoll, Jordan J Green

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 238 citations in OpenAlex.

  1. Review
  2. Nanomaterials-Based Immunotherapy for Atherosclerosis.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  3. Review
  4. Review
  5. Mesenchymal Stromal Cell-Based Cell-Drug Conjugates for the Treatment of Acute Liver Failure.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Immunomodulatory Delivery Materials for Tissue Repair.Advanced healthcare materials · 2025
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Elana Ben-AkivaDepartments of Biomedical Engineering, Materials Science and Engineering, Chemical and Biomolecular Engineering, and Oncology, Translational Tissue Engineering Center, Institute for Nanobiotechnology, Johns Hopkins School of Medicine, 400 N Broadway, Smith Building 5017, Baltimore, MD 21231, USA.ORCID 0000-0003-1085-5902
Randall A MeyerDepartments of Biomedical Engineering, Materials Science and Engineering, Chemical and Biomolecular Engineering, and Oncology, Translational Tissue Engineering Center, Institute for Nanobiotechnology, Johns Hopkins School of Medicine, 400 N Broadway, Smith Building 5017, Baltimore, MD 21231, USA.
Hongzhe YuDepartments of Biomedical Engineering, Materials Science and Engineering, Chemical and Biomolecular Engineering, and Oncology, Translational Tissue Engineering Center, Institute for Nanobiotechnology, Johns Hopkins School of Medicine, 400 N Broadway, Smith Building 5017, Baltimore, MD 21231, USA.
Jonathan T SmithDepartments of Biomedical Engineering, Materials Science and Engineering, Chemical and Biomolecular Engineering, and Oncology, Translational Tissue Engineering Center, Institute for Nanobiotechnology, Johns Hopkins School of Medicine, 400 N Broadway, Smith Building 5017, Baltimore, MD 21231, USA.
Drew M PardollBloomberg-Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.ORCID 0000-0001-6215-1013
Jordan J GreenDepartments of Biomedical Engineering, Materials Science and Engineering, Chemical and Biomolecular Engineering, and Oncology, Translational Tissue Engineering Center, Institute for Nanobiotechnology, Johns Hopkins School of Medicine, 400 N Broadway, Smith Building 5017, Baltimore, MD 21231, USA.ORCID 0000-0003-4176-3808
Johns Hopkins University · US

Funding

T32: Predoctoral and Postdoctoral Training Program in Nanotechnology for Cancer ResearchT32CA153952 · NCI · JOHNS HOPKINS UNIVERSITY · PI Denis Wirtz · 2015 to 2026
$3.5M
Gene Delivery Nanoparticles to Treat GlioblastomaR01CA228133 · NCI · JOHNS HOPKINS UNIVERSITY · PI GREEN, JORDAN · 2019 to 2023
$1.9M
Cancer-specific nanoparticle-mediated gene therapy to treat hepatocellular carcinomaR01EB022148 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI GREEN, JORDAN · 2016 to 2019
$1.5M
T-32 NIH Postdoctoral Training Program in Nanotechnology for Cancer Medicine NTCMT32CA130840 · NCI · JOHNS HOPKINS UNIVERSITY · PI WIRTZ, DENIS · 2008 to 2012
$1.2M
Biomimetic artificial antigen presenting cells for melanoma immunotherapyF31CA214147 · NCI · JOHNS HOPKINS UNIVERSITY · PI MEYER, RANDALL A · 2016 to 2017
$88k
NCI NIH HHS F31 CA214147NCI NIH HHS R01 CA228133NCI NIH HHS T32 CA130840NCI NIH HHS T32 CA153952NIBIB NIH HHS R01 EB022148
6 · The paper itself

Abstract

The design of next-generation nanobiomaterials requires precise engineering of both physical properties of the core material and chemical properties of the material's surface to meet a biological function. A bio-inspired modular and versatile technology was developed to allow biodegradable polymeric nanoparticles to circulate through the blood for extended periods of time while also acting as a detoxification device. To mimic red blood cells, physical and chemical biomimicry are combined to enhance the biological function of nanomaterials in vitro and in vivo. The anisotropic shape and membrane coating synergize to resist cellular uptake and reduce clearance from the blood. This approach enhances the detoxification properties of nanoparticles, markedly improving survival in a mouse model of sepsis. The anisotropic membrane-coated nanoparticles have enhanced biodistribution and therapeutic efficacy. These biomimetic biodegradable nanodevices and their derivatives have promise for applications ranging from detoxification agents, to drug delivery vehicles, and to biological sensors.

Indexed as

Biomimetic MaterialsNanoparticlesAnimalsBiomimeticsCell MembraneErythrocyte MembraneMicePolymersTissue DistributionPolymers

Identifiers

PMID32490199
PMCPMC7239698
OpenAlexW3016544053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.